105 Results (Page 1 of 9)
Canada Markets Research Reports
Canada Anti Aging Therapeutics Market Analysis
Canada's anti-aging therapeutics market is likely to grow at a CAGR of 16.53% from a market size of $54 Mn in 2022 to $164 Mn in 2030. The major growth drivers driving the market are the growing aging population and the trend of the shift toward preventive healthcare. This report is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some key players in this market include Pfizer, Bristol-Myers Squibb Company, Merck, Calico, and others.
Canada Radiotherapy Market Analysis
Canada radiotherapy market is likely to grow at a CAGR of 6% from a market size of $552.8 Mn in 2022 to $881 Mn in 2030. The rising incidence of cancer and the technological advancements in radiotherapy acts as a market growth driver. This report is segmented by type, technology, application, and by end user. Some key players in this market include Siemens Healthineers, Elekta Accuray Incorporated, Hitachi, IsoRay, Zeiss group, and others.
Canada Oncology Therapeutics Market Analysis
Canada oncology therapeutics market is likely to grow at a CAGR of 8.4% from a market size of $14.53 Bn in 2022 to $27.7 Bn in 2030. The market is growing primarily due to the rise in cancer prevalence, population growth, and increased consumer knowledge of cancer therapies. Oncology drug market growth in Canada is anticipated to be constrained by the high development costs for new drugs, failure risk, and unfavorable side effects of anti-cancer drug therapy. This report is segmented by application, by drugs, by therapy, by route of administration, and by distribution channel. Some key players in this market include AstraZeneca, GlaxoSmithKline, Eli Lilly, Roche diagnostics, Novartis, Pfizer, Merck, Gilead, Sanofi, Celgene Corporation, and others.
Canada Lung Cancer Therapeutics Market Analysis
Canada's lung cancer therapeutics market is likely to grow at a CAGR of 8.11% from a market size of $2.34 Bn in 2022 to $4.44 Bn in 2030. One of the main factors propelling the growth of the lung cancer treatments market is the increase in the adoption of unhealthy lifestyles, such as smoking. Lung cancer is known to be frequently caused by cigarette smoking. This report is segmented by type, therapy, type of molecule, drug class, and by distribution channel. Some key players in this market include Sanofi, Bristol-Myers & Squibb, Pfizer, AstraZeneca, Celgene Corporation, Boehringer Ingelheim, J&J, and others.
Canada Liver Diseases Therapeutics Market Analysis
Canada's liver disease therapeutics market is likely to grow at a CAGR of 5.7% from a market size of $1.84 Bn in 2022 to $2.87 Bn in 2030. The increase in alcohol consumption along with the change in lifestyle and increasing geriatric population acts as a market growth driver. This report is segmented by treatment type, disease type, and by distribution channel. Some key players in this market include AbbVie, Novartis, Bristol-Myers & Squibb, Merck, Roche, Eli Lilly, and others.
Canada ENT Devices Market Analysis
Canada ENT device market is likely to grow at a CAGR of 5.75% from a market size of $1.85 Bn in 2022 to $2.89 Bn in 2030. The use of emerging technologies like AI and ML as well as developments in auditory products are boosting the industry's growth. This report is segmented by product type, diagnostic devices, surgical devices, and the end user. Some key players in this market include Sonova, Pentax Medical, Karl Storz, Olympus Corporation, Richard Wolf, Cochlear, Stryker, and others.
Canada Cardiovascular Diseases Therapeutics Market Analysis
Canada's cardiovascular disease therapeutics market is likely to grow at a CAGR of 7.22% from a market size of $13.01 Bn in 2022 to $22.72 Bn in 2030. Rising cardiovascular disease prevalence and growing R&D are the major market driver. This report is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by end users. Some key players in this market include Johnson and Johnson, Gilead, AstraZeneca, Novartis, Roche, Merck, Pfizer, and others.
Canada Biomaterials in Healthcare Market Analysis
Canada's biomaterials in the healthcare market are likely to grow at a CAGR of 13.20% from a market size of $12.5 Bn in 2022 to $33.7 Bn in 2030. Market growth is driven mainly by factors such as increasing demand for medical implants and the sudden rise in cardiovascular diseases. This report is segmented by type and by application. Some key players in this market include Celanese Corporation, Berkeley Advanced Biomaterials, Stryker Corporation, Zimmer Biomet Holdings, and others.
Canada Advanced Therapy Medicinal Products (ATMPs) Market Analysis
Canada's Advanced Therapy Medicinal Products (ATMPs) market is likely to grow at a CAGR of 13% from a market size of $0.81 Bn in 2022 to $2.15 Bn in 2030. The major growth drivers driving the market are the increasing prevalence of chronic diseases and the growing investment in the industry. This report is segmented by product type, disease type, and by distribution channel. Some key players in this market include Novartis, Celgene Corporation, Gilead Lifesciences, Bluebird Bio, and others.
Canada Cardiac Monitoring Devices Market Analysis
Canada's cardiac monitoring device market is likely to grow at a CAGR of 4.7% from a market size of $2.31 Bn in 2022 to $3.34 Bn in 2030. The main key factor driving the market is the penetration of smart technology in cardiac monitoring devices and the increasing prevalence of cardiac diseases. This report is segmented by product type and by the end user. Some key players in this market include Medtronic, Abbott, Koninklijke Philips, Boston Scientific Corporation, GE Healthcare, Hill-Rom Holdings, Schiller, and others.
Canada Cancer Immunotherapy Market Analysis
Canada's cancer immunotherapy market is likely to grow at a CAGR of 7.1% from a market size of $9 Bn in 2022 to $15.58 Bn in 2030. Rising cancer prevalence and growing adoption of immunotherapy are the major market driver. This report is segmented by type, application, and by distribution channel. Some key players in this market include Johnson and Johnson, Eli Lilly, Novartis, Roche, Merck, Pfizer, and others.
Canada Liver Cancer Therapeutics Market Analysis
Canada's liver cancer therapeutics market is likely to grow at a CAGR of 17.6% from a market size of $234 Mn in 2022 to $857 Mn in 2030. The increase in awareness among the people regarding the disease and the increasing prevalence of the disease drives the market growth This report is segmented by treatment, type, equipment, route of administration, and the end user. Some key players in this market include Bayer, Bristol-Myers & Squibb, Pfizer, Merck, Roche, Eli Lilly, and others.
Canada Infectious Disease Therapeutics Market Analysis
Canada's infectious disease therapeutics market is likely to grow at a CAGR of 4.35% from a market size of $9.59 Bn in 2022 to $13.48 Bn in 2030. The increase in the prevalence of infectious diseases in Canada and the increasing government initiatives to provide facilities to patients has acted as a market growth driver. This report is segmented by mode of treatment, applications, disease type, target organisms, and end user. Some key players in this market include Novartis, Roche, Janssen Pharmaceutical, Merck, BI, and others.
Canada Connected Healthcare Market Analysis
Canada connected healthcare market is likely to grow at a CAGR of 28.4% from a market size of $5.309 Bn in 2022 to $39.221 Bn in 2030. A healthcare management system called connected healthcare uses technology to deliver medical services remotely. The utilization of mHealth tools, mHealth services, and e-prescription are all included. The market is expected to rise as a result of factors like expanding healthcare-related research, improved interoperability, digital data management, and active government backing. This report is segmented by type, function type, application type, and by the end user. Some key players in this market include Allscripts, Cerner, Philips, McKesson, IBM Corporation, and others.
Canada Healthcare Claims Management Market Analysis
Canada's healthcare claims management market is likely to grow at a CAGR of 23.4% from a market size of $2.13 Bn in 2022 to $11.48 Bn in 2030. The rise in research and development expenditure in healthcare along with the new technological advancements and the increasing trend of automation in healthcare acts as a growth factor for the market. This report is segmented by component, type, delivery mode, and by end user. Some key players in this market include Accenture, Allscripts, Cerner, AthenaHealth, McKesson, IBM Corporation, and others.
Canada Healthcare Financial Analytics Market Analysis
The Canada Healthcare Financial Analytics market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.8% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by type, component, and deployment. Canada’s Healthcare Financial Analytics market will grow as the rising cost of healthcare in Canada is driving the need for financial analytics solutions that can help healthcare organizations manage and optimize their spending. The key market players are IBM Watson Health, Healthtech Consultants, MedeAnalytics, McKesson, and others.
Canada Telemedicine Market Analysis
The Canada Telemedicine market was valued at $4.864 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 18.2% from 2022 to 2030 and will reach $18.532 Bn in 2030. One of the main reasons propelling the growth of this market is the advent of advanced technologies, rising cases of chronic and lifestyle related disease. The market is segmented by end user, product type and Delivery mode. Some key players in this market are Cerner Corporation, GE Healthcare, Physiotherapy Ltd etc.
Canada Digital Health Market Analysis
The Canada digital market size was valued at $16.88 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 18.6% from 2022 to 2030 and will reach $66.07 Bn in 2030. The rising popularity of remote patient monitoring services will drive Canada home healthcare market expansion. The market is segmented by solution, deployment, and end user. the key market players are MEDITECH, Oracle Cerner Corporation, Epic Systems Corporation, and others.
Canada Dental Care Market Analysis
The Canada dental care market was valued at $2.87 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.4% from 2022 to 2030 and will reach $4.72 Bn in 2030. One of the main reasons propelling the growth of this market demand for primary and postoperative care of higher quality, technological advancements and rising incidence of tooth decay among younger generations. The market is segmented by product, age group, and by sales services. Some key players in this market are (Dentalcorp Holdings Ltd., 123Dentist, Altima Dental Canada Holdings Inc., Canadian Orthodontics Partners (COP), Teeth First Dental, and MCA Dental Group Limited).
Canada Oral Care Market Analysis
The Canada Oral Care market was valued at $2.8 Bn in 2022 and is estimated to expand at a CAGR of 6.2% from 2022 to 2030 and will reach $4.5 Bn in 2030. One of the main reasons propelling the growth of this market is introduction of newer technologies, aging population. The market is segmented by type, drug and distribution channel. Some key players in this market are Sun Pharmaceutical Industries, Altima Dental, Dental Solutions, Millenium Dental , Dentalcorp, 123Dentist among others.
Canada Multiple Myeloma Therapeutics Market Analysis
The Canada Multiple Myeloma Therapeutics Market was valued at $667 Mn in 2022 and is estimated to expand at a CAGR of 4.5% from 2022 to 2030 and will reach $849 Mn in 2030. One of the main reasons propelling the growth of this Market is the increasing adoption of combination therapies, and technological advancements. The Market is segmented by type, drug and distribution channel. Some key players in this market are Apobiologix, Knight Therapeutics., Medexus Pharmaceuticals, Therapure Biopharma, Bloom Burton & Co., and others.
Canada Diabetes Drugs Market Analysis
The Canada diabetes drugs market size was valued at $4.94 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.1% from 2022 to 2030 and will reach $7.93 Bn in 2030. The market is segmented by drug type, application, and distribution channel. The Canada diabetes drug market will grow as the Canadian population continues to age, and the incidence of diabetes is expected to increase. The key market players are Insulet Corporation, Sanofi, Johnson & Johnson, Abbott, Bayer Pharmaceuticals, Novo Nordisk, and others.
Canada Anti-Depressants Drugs Market Analysis
The Canada Anti-Depressants drugs market size was valued at $1.31Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.9% from 2022 to 2030 and will reach $2.08 Bn in 2030. The market is segmented by drug class, indication, route of administration, end-user, and distribution channel. The Canada Anti-Depressants drug market will grow because of the development of novel antidepressant drugs and the expansion of the product portfolio of pharmaceutical companies. The key market players Apotex Inc, Lundbeck Canada Inc, Purdue Pharma Canada, Janssen Inc., Paladin Labs Incand others.
Canada Anemia Drugs Market Analysis
Canada's Anemia drugs market was valued at $1.28 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.9% from 2022 to 2030 and will reach $2.53 Bn in 2030. One of the main reasons propelling the growth of this market is introduction of newer technologies, aging population. The market is segmented by type, drug and distribution channel. Some key players in this market are, Amgen, Roche, Takeda Pharmaceutical, Sanofi, and Novartis among others.
Canada Artificial Intelligence (AI) in Medical Imaging Market Analysis
The Canada Artificial Intelligence (AI) in Medical Imaging market size was valued at $120 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 35.4% from 2022 to 2030 and will reach $1356Mn. The market is segmented by AI technology, solution, modality, application, and end User. The Canada Artificial Intelligence (AI) in the Medical Imaging market will grow due to advances in AI and machine learning algorithms that are making it possible to develop more accurate and efficient medical imaging software. Some of the key players in this market are Imagia, Intelerad Medical Systems, Aifred Health, HeartForce Medical, Swift Medical, Resolution Health, Hooton AI (Vancouver, British Columbia) and others.